May 07, 2024 / 09:00PM GMT
Operator
Good afternoon, and welcome to AbCellera's Q1 2024 business update conference call. My name is Harry, and I will facilitate the audio portion of today's interactive broadcast. (Operator Instructions)
At this time, I would like to turn the call over to Tryn Stimart, AbCellera's Chief Legal and Compliance Officer. Please go ahead.
Tryn Stimart - Abcellera Biologics Inc - Chief Compliance Officer, Corporate Secretary, Chief Legal Officer
Good morning, good afternoon, and good evening to everyone listening around the world. Thank you for joining us for Abcellera's 2024 first-quarter earnings call. I'm Tryn Stimart, Abcellera's Chief Legal and Compliance Officer.
Joining me on today's call are Dr. Carl Hansen, Abcellera's President and CEO; and Andrew Booth, Abcellera's Chief Financial Officer. During this call, we anticipate making projections and forward-looking statements based on our current expectations and pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995.
Our actual results could differ
Q1 2024 Abcellera Biologics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot